Substance P-Mediated Vascular Protection Ameliorates Bone Loss
暂无分享,去创建一个
[1] K. Cheng,et al. Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy , 2022, Journal of Nanobiotechnology.
[2] H. Hong,et al. Substance-P Inhibits Cardiac Microvascular Endothelial Dysfunction Caused by High Glucose-Induced Oxidative Stress , 2021, Antioxidants.
[3] Jeong Seop Park,et al. Substance P blocks ovariectomy-induced bone loss by modulating inflammation and potentiating stem cell function , 2020, Aging.
[4] Jeong Seop Park,et al. Substance-P Restores Cellular Activity of ADSC Impaired by Oxidative Stress , 2020, Antioxidants.
[5] Suna Kim,et al. Substance P enhances the therapeutic effect of MSCs by modulating their angiogenic potential , 2020, Journal of cellular and molecular medicine.
[6] Jeong Seop Park,et al. Substance P blocks β-aminopropionitrile-induced aortic injury through modulation of M2 monocyte-skewed monocytopoiesis. , 2020, Translational research : the journal of laboratory and clinical medicine.
[7] W. Jing,et al. Motivating role of type H vessels in bone regeneration , 2020, Cell proliferation.
[8] Liang Xie,et al. Unique bone marrow blood vessels couple angiogenesis and osteogenesis in bone homeostasis and diseases , 2020, Annals of the New York Academy of Sciences.
[9] Q. Yao,et al. Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis , 2020, Nature Communications.
[10] H. Yokota,et al. eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice , 2019, Cell Death & Disease.
[11] Jeong Seop Park,et al. Substance P accelerates wound repair by promoting neovascularization and preventing inflammation in an ischemia mouse model , 2019, Life sciences.
[12] Changjun Li,et al. The association between CD31hiEmcnhi endothelial cells and bone mineral density in Chinese women , 2019, Journal of Bone and Mineral Metabolism.
[13] Jin Fan,et al. GIT1 is critical for formation of the CD31hiEmcnhi vessel subtype in coupling osteogenesis with angiogenesis via modulating preosteoclasts secretion of PDGF-BB. , 2019, Bone.
[14] Suna Kim,et al. Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated Inflammation. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
[15] Li Yang,et al. Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model. , 2018, Journal of ethnopharmacology.
[16] H. Hong,et al. Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro , 2018, Microcirculation.
[17] Xu Cao,et al. Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice , 2018, Theranostics.
[18] H. Hong,et al. Endothelial precursor cells stimulate pericyte‐like coverage of bone marrow‐derived mesenchymal stem cells through platelet‐derived growth factor‐BB induction, which is enhanced by substance P , 2017, Microcirculation.
[19] M. Brandi,et al. Oxidative stress in bone remodeling: role of antioxidants. , 2017, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[20] P. Zhang,et al. Human type H vessels are a sensitive biomarker of bone mass , 2017, Cell Death & Disease.
[21] H. Hong,et al. Genotoxicity studies of substance-P by using short-term assay , 2016, Molecular & Cellular Toxicology.
[22] R. Adams,et al. Blood vessel formation and function in bone , 2016, Development.
[23] Suna Kim,et al. Substance P promotes diabetic wound healing by modulating inflammation and restoring cellular activity of mesenchymal stem cells , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[24] H. Hong,et al. Evaluation of substance-P toxicity with single dose and repeated dose in rats , 2015, Molecular & Cellular Toxicology.
[25] S. Chatterjee,et al. Role of angiogenesis in bone repair. , 2014, Archives of biochemistry and biophysics.
[26] R. Adams,et al. Osteoclast progenitors promote bone vascularization and osteogenesis , 2014, Nature Medicine.
[27] E. M. Lewiecki,et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.
[28] L. Duong,et al. PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.
[29] R. Adams,et al. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.
[30] D. Monleón,et al. Early , But Not Late Onset Estrogen Replacement Therapy Prevents Oxidative Stress and Metabolic Alterations Caused by Ovariectomy , 2014 .
[31] V. Huxley,et al. Pulsed Estrogen Therapy Prevents Post-OVX Porcine Dura Mater Microvascular Network Weakening via a PDGF-BB-Dependent Mechanism , 2013, PloS one.
[32] J. Richtsmeier,et al. Angiogenesis and intramembranous osteogenesis , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.
[33] C. Hermenegildo,et al. Vascular Aging in Women: is Estrogen the Fountain of Youth? , 2012, Front. Physio..
[34] A. Caplan,et al. PDGF in bone formation and regeneration: New insights into a novel mechanism involving MSCs , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[35] David Handelsman,et al. Minireview: rapid actions of sex steroids in the endothelium. , 2010, Endocrinology.
[36] L. Dai,et al. Changes of substance P during fracture healing in ovariectomized mice , 2010, Regulatory Peptides.
[37] Jacques P. Brown,et al. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] N. Vaziri. Causal link between oxidative stress, inflammation, and hypertension. , 2008, Iranian journal of kidney diseases.
[39] Dean P. Jones,et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation , 2007, Proceedings of the National Academy of Sciences.
[40] T. Chambers,et al. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. , 2005, Endocrinology.
[41] T. Lesnick,et al. Expression of estrogen receptor isoforms α and β messenger RNA in vaginal tissue of premenopausal and postmenopausal women , 2001 .
[42] L. Bae,et al. Estrogen increases eNOS and NOx release in human coronary artery endothelium. , 2000, Journal of cardiovascular pharmacology.
[43] K. Murayama,et al. Inactivation of Human Manganese-superoxide Dismutase by Peroxynitrite Is Caused by Exclusive Nitration of Tyrosine 34 to 3-Nitrotyrosine* , 1998, The Journal of Biological Chemistry.
[44] J. Thompson,et al. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. , 1998, Biochemistry.
[45] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.